Stacey N Lee

5PUBLICATIONS
20CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 09, 2026
Adenosine drives suppression of CD16low NK cell responses against HGSC via NKG2A:hLA-E interactions.

Anna P Nicolela, Sarah Nersesian, Stacey N Lee

|Feb 24, 2026
Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition.

Stacey N Lee, Riley J Arseneau, Thomas Arnason

|Oct 25, 2024
Canadian National Pancreas Conference 2023: A Review of Multidisciplinary Engagement in Pancreatic Cancer Care.

Jessica L Nickerson, Chloe Cyr, Riley J Arseneau

|Oct 23, 2023
BioCanRx Summit for Cancer Immunotherapy 2022 Proceedings.

Stacey N Lee, Victoria Hoskin, Céline M Laumont

|Jul 27, 2022
PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology.

Ryan DeCoste, Yutaka Amemiya, Sarah Nersesian

Pageof 1

Frequent Collaborators

3 joint publications

Sarah Nersesian

3 joint publications

Jeanette E Boudreau

2 joint publications

Riley J Arseneau

1 joint publications

Ryan DeCoste